Xylem Rises After Earnings Beat and Higher 2026 Profit Outlook

Xylem Inc. (XYL) is up 4.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to Xylem’s second-quarter earnings release, which showed stronger profitability and a higher full-year adjusted EPS outlook. Investors also seem to be reacting favorably to margin expansion and management’s comments that demand linked to AI infrastructure is broadening water-related spending across industrial markets.

Details:

Xylem posted second-quarter adjusted earnings per share of $1.46, while net income attributable to the company rose to $263 million.

The company raised its 2026 adjusted EPS guidance to $5.55 to $5.70 from $5.35 to $5.60, a clear positive signal for profit expectations.

Second-quarter adjusted EBITDA margin reached 23.3%, up 150 basis points year over year, helped by productivity savings, price realization, and business mix.

Management said the growth of AI infrastructure is increasing the importance of water solutions across areas such as semiconductors, power generation, mining, food and beverage, and life sciences.

Sources:

Xylem, SEC, MarketScreener

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$XYL Insider Trading Activity

$XYL insiders have traded $XYL stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $XYL stock by insiders over the last 6 months:

JEROME A PERIBERE purchased 1,210 shares for an estimated $141,098

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive XYL Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$XYL Hedge Fund Activity

We have seen 449 institutional investors add shares of $XYL stock to their portfolio, and 515 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

J. STERN & CO. LLP removed 45,161,096 shares (-99.4%) from their portfolio in Q1 2026, for an estimated $5,317,944,859
SWEDBANK AB removed 1,566,210 shares (-28.3%) from their portfolio in Q2 2026, for an estimated $185,141,684
PRICE T ROWE ASSOCIATES INC /MD/ removed 1,299,322 shares (-73.6%) from their portfolio in Q1 2026, for an estimated $153,001,662
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 1,198,149 shares (-80.2%) from their portfolio in Q1 2026, for an estimated $141,088,035
ARTISAN PARTNERS LIMITED PARTNERSHIP removed 939,244 shares (-29.2%) from their portfolio in Q1 2026, for an estimated $110,600,677
VOYA INVESTMENT MANAGEMENT LLC removed 889,811 shares (-88.6%) from their portfolio in Q1 2026, for an estimated $104,779,694
SCHRODER INVESTMENT MANAGEMENT GROUP removed 755,448 shares (-48.8%) from their portfolio in Q1 2026, for an estimated $88,957,779

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$XYL Price Targets

Multiple analysts have issued price targets for $XYL recently. We have seen 8 analysts offer price targets for $XYL in the last 6 months, with a median target of $158.5.

Here are some recent targets:

Stephen Volkmann from Jefferies set a target price of $140.0 on 06/25/2026
Nathan Jones from Stifel set a target price of $159.0 on 04/29/2026
William Grippin from Barclays set a target price of $154.0 on 04/29/2026
Andrew Kaplowitz from Citigroup set a target price of $168.0 on 04/29/2026
Bryan Blair from Oppenheimer set a target price of $158.0 on 04/29/2026
Joshua Spector from UBS set a target price of $133.0 on 04/29/2026
Mark Strouse from JP Morgan set a target price of $160.0 on 04/16/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.